MBX Biosciences, Inc. (MBX) EBITDA

Annual EBITDA:

-$67.95M-$32.80M(-93.29%)
December 31, 2024

Summary

  • As of today, MBX annual EBITDA is -$67.95 million, with the most recent change of -$32.80 million (-93.29%) on December 31, 2024.
  • During the last 3 years, MBX annual EBITDA has fallen by -$42.24 million (-164.35%).
  • MBX annual EBITDA is now -164.35% below its all-time high of -$25.70 million, reached on December 1, 2022.

Performance

1-Year Change

-93.29%

3-Year Change

-164.35%

5-Year Change

-164.35%

15-Year Change

-164.35%

MBX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

23.48%
MBX annual EBITDA is higher than 23.48% of companies in Healthcare sector

Range

All-Time High

-$25.70M
MBX annual EBITDA is currently -164.35% below its historical high of -$25.70 million

3-Year Low

-$67.95M
MBX annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
MBX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 16, 2026
MBX next annual earnings announcement is scheduled for Mar 16, 2026

OtherMBXincome statement metrics

Annual Revenue

$0.00
MBX annual revenue is $0.00

Annual Net Income

-$61.92M
MBX annual net profit is -$61.92 million

Annual EBIT

-$68.19M
MBX annual earnings before interest & taxes is -$68.19 million

Annual EPS

-$1.85
MBX annual earnings per share is -$1.85

Quarterly EBITDA:

-$23.83M-$2.12M(-9.77%)
September 30, 2025

Summary

  • As of today, MBX quarterly EBITDA is -$23.83 million, with the most recent change of -$2.12 million (-9.77%) on September 30, 2025.
  • Over the past year, MBX quarterly EBITDA has dropped by -$4.31 million (-22.11%).
  • MBX quarterly EBITDA is now -276.40% below its all-time high of -$6.33 million, reached on March 1, 2023.

Performance

3-Month Change

-9.77%

1-Year Change

-22.11%

3-Year Change

-276.4%

5-Year Change

-276.4%

MBX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

18.09%
MBX quarterly EBITDA is higher than 18.09% of companies in Healthcare sector

Range

All-Time High

-$6.33M
MBX quarterly EBITDA is currently -276.40% below its historical high of -$6.33 million

3-Year Low

-$26.45M
MBX quarterly EBITDA is currently +9.93% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
MBX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 16, 2026
MBX next earnings announcement is scheduled for Mar 16, 2026

OtherMBXincome statement metrics

Quarterly Revenue

$0.00
MBX quarterly revenue is $0.00

Quarterly Net Income

-$21.62M
MBX quarterly net profit is -$21.62 million

Quarterly EBIT

-$23.93M
MBX quarterly earnings before interest & taxes is -$23.93 million

Quarterly EPS

-$0.63
MBX quarterly earnings per share is -$0.63

TTM EBITDA:

-$90.53M-$4.31M(-5.00%)
September 30, 2025

Summary

  • As of today, MBX TTM EBITDA is -$90.53 million, with the most recent change of -$4.31 million (-5.00%) on September 30, 2025.
  • Over the past year, MBX TTM EBITDA has dropped by -$41.16 million (-83.37%).
  • MBX TTM EBITDA is now -1330.25% below its all-time high of -$6.33 million, reached on March 1, 2023.

Performance

3-Month Change

-5%

1-Year Change

-83.37%

3-Year Change

-1330.25%

5-Year Change

-1330.25%

MBX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

18.81%
MBX TTM EBITDA is higher than 18.81% of companies in Healthcare sector

Range

All-Time High

-$6.33M
MBX TTM EBITDA is currently -1330.25% below its historical high of -$6.33 million

3-Year Low

-$90.53M
MBX TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
MBX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 16, 2026
MBX next earnings announcement is scheduled for Mar 16, 2026

OtherMBXincome statement metrics

TTM Revenue

$0.00
MBX TTM revenue is $0.00

TTM Net Income

-$80.50M
MBX TTM net profit is -$80.50 million

TTM EBIT

-$90.87M
MBX TTM earnings before interest & taxes is -$90.87 million

TTM EPS

-$2.39
MBX TTM earnings per share is -$2.39

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$67.95M
MBX annual EBITDA is -$67.95 million

Annual Net Income

-$61.92M
MBX annual net profit is -$61.92 million

Annual Interest Expense

$0.00
MBX annual interest expense is $0.00

Annual Income Tax

$0.00
MBX annual income tax is $0.00

Annual D&A

$244.00K
MBX annual D&A is $244.00 thousand

MBX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-93.3%-22.1%-83.4%
3Y3 Years-164.3%-276.4%-1330.3%
5Y5 Years-164.3%-276.4%-1330.3%

MBX EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-164.3%at low-276.4%+9.9%-1330.3%at low
5Y5-Year-164.3%at low-276.4%+9.9%-1330.3%at low
All-TimeAll-Time-164.3%at low-276.4%+9.9%-1330.3%at low

MBX EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$23.83M(-9.8%)
-$90.53M(-5.0%)
Jun 2025
-
-$21.70M(+17.9%)
-$86.22M(-6.3%)
Mar 2025
-
-$26.45M(-42.6%)
-$81.11M(-19.4%)
Dec 2024
-$67.95M
-$18.55M(+4.9%)
-$67.92M(-37.6%)
Sep 2024
-
-$19.51M(-17.6%)
-$49.37M(-21.3%)
Jun 2024
-
-$16.59M(-25.1%)
-$40.71M(-26.9%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$13.27M(-22.3%)
-$32.08M(-27.6%)
Dec 2023
-$35.15M(-36.8%)
-
-
Sep 2023
-
-$10.85M(-36.1%)
-$25.14M(-75.8%)
Jun 2023
-
-$7.97M(-25.9%)
-$14.30M(-125.9%)
Mar 2023
-
-$6.33M
-$6.33M
Dec 2022
-$25.70M
-
-

FAQ

  • What is MBX Biosciences, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for MBX Biosciences, Inc.?
  • What is MBX Biosciences, Inc. annual EBITDA year-on-year change?
  • What is MBX Biosciences, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for MBX Biosciences, Inc.?
  • What is MBX Biosciences, Inc. quarterly EBITDA year-on-year change?
  • What is MBX Biosciences, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for MBX Biosciences, Inc.?
  • What is MBX Biosciences, Inc. TTM EBITDA year-on-year change?

What is MBX Biosciences, Inc. annual EBITDA?

The current annual EBITDA of MBX is -$67.95M

What is the all-time high annual EBITDA for MBX Biosciences, Inc.?

MBX Biosciences, Inc. all-time high annual EBITDA is -$25.70M

What is MBX Biosciences, Inc. annual EBITDA year-on-year change?

Over the past year, MBX annual EBITDA has changed by -$32.80M (-93.29%)

What is MBX Biosciences, Inc. quarterly EBITDA?

The current quarterly EBITDA of MBX is -$23.83M

What is the all-time high quarterly EBITDA for MBX Biosciences, Inc.?

MBX Biosciences, Inc. all-time high quarterly EBITDA is -$6.33M

What is MBX Biosciences, Inc. quarterly EBITDA year-on-year change?

Over the past year, MBX quarterly EBITDA has changed by -$4.31M (-22.11%)

What is MBX Biosciences, Inc. TTM EBITDA?

The current TTM EBITDA of MBX is -$90.53M

What is the all-time high TTM EBITDA for MBX Biosciences, Inc.?

MBX Biosciences, Inc. all-time high TTM EBITDA is -$6.33M

What is MBX Biosciences, Inc. TTM EBITDA year-on-year change?

Over the past year, MBX TTM EBITDA has changed by -$41.16M (-83.37%)
On this page